Categories AlphaGraphs, Earnings, Health Care

AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.

AbbVie Q4 2024 earnings infographic

The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.

Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.

Prior Performance

  • AbbVie Q2 2024 earnings infographic
  • AbbVie Q1 2024 earnings infographic
  • AbbVie Q4 2023 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

MS Earnings: Morgan Stanley Q1 2025 revenue and earnings beat estimates

Morgan Stanley (NYSE: MS) on Friday reported higher revenues and net profit for the first quarter of 2025. The latest numbers also exceeded analysts’ estimates. The company reported net revenues

WFC Earnings: Key quarterly highlights from Wells Fargo’s Q1 2025 financial results

Wells Fargo & Company (NYSE: WFC) reported its first quarter 2025 earnings results today. Total revenue decreased 3% year-over-year to $20.15 billion. Net income grew 6% to $4.89 billion and

JPM Earnings: All you need to know about JPMorgan’s Q1 2025 earnings results

JPMorgan Chase & Co. (NYSE: JPM) reported its first quarter 2025 earnings results today. Reported net revenue increased 8% year-over-year to $45.3 billion. Managed net revenue was $46 billion, also

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close